Nektar Therapeutics · NASDAQ:NKTR
Zalevsky Jonathan sold 199 Nektar Therapeutics shares (Form 4)
Traded May 19, 2026 · Filed May 21, 2026
On May 19, 2026, Zalevsky Jonathan (Chief R&D Officer) sold 199 Nektar Therapeutics shares at US$65.51 for US$13,036, leaving 20,975 shares. Filed May 21, 2026 (Form 4).
- Sold
- 199 shares
- Price
- US$65.51
- Value
- US$13,036
- Holding after
- 20,975 shares
- Trading plan
- No
- Role
- Chief R&D Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 19, 2026 | Common Stock | Sale | 199 | US$65.51 | 20,975 | Direct |
Source
Related
- Nektar Therapeutics
- Zalevsky Jonathan
- Nektar Therapeutics shareholders
- Form 4 · Zalevsky Jonathan · Aug 20, 2026
- Form 4 · Zalevsky Jonathan · Jul 2, 2026
- Form 4 · Zalevsky Jonathan · Jun 17, 2026
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026